Evidence map›Paper›PMID 28301459›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1.

Jamal Ghoumid, Morgane Stichelbout, Anne-Sophie Jourdain, Frederic Frenois, Sophie Lejeune-Dumoulin, Marie-Pierre Alex-Cordier, Marine Lebrun, Pierre Guerreschi, Veronique Duquennoy-Martinot, Matthieu Vinchon and 7 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07133464 (CDH1-associated Blepharocheilodontic Syndrome Registry), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07133464 recruitingnot on this mapstarted 2025, after this paper: background citation

CDH1-associated Blepharocheilodontic Syndrome Registry

Typeobservational_patient_registrySponsorOhio State UniversityRan2025 to 2040Enrolled100ConditionsBlepharocheilodontic Syndrome
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 68 citations in OpenAlex.

  1. Germline whole-exome sequencing identifies CTNND1 as a candidate gene for hereditary gastric cancer in a large Brazilian cohort.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Functional analysis ofbioRxiv : the preprint server for biology · 2024
    Article
  11. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  12. Review
  13. Frequency ofCancers · 2023
    Article
  14. Case Series of 11Genes · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. A NovelDiagnostics (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Jamal GhoumidDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.ORCID 0000-0002-7111-0050
Morgane StichelboutDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.
Anne-Sophie JourdainEA7364 RADEME (Research Team on Rare Developmental and Metabolic Diseases), Lille 2 University, Lille, France.
Frederic FrenoisDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.
Sophie Lejeune-DumoulinDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.
Marie-Pierre Alex-CordierDepartment of Medical Genetics, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, and Eastern Biology and Pathology Centre, Bron, France.ORCID 0000-0002-7889-4863
Marine LebrunDepartment of Medical Genetics, St Etienne University Hospital, Saint Priez en Jarez, France.
Pierre GuerreschiEA7364 RADEME (Research Team on Rare Developmental and Metabolic Diseases), Lille 2 University, Lille, France.ORCID 0000-0002-2955-5291
Veronique Duquennoy-MartinotEA7364 RADEME (Research Team on Rare Developmental and Metabolic Diseases), Lille 2 University, Lille, France.
Matthieu VinchonEA7364 RADEME (Research Team on Rare Developmental and Metabolic Diseases), Lille 2 University, Lille, France.
Joel FerriLille University School of Medicine, Lille 2 University, Lille, France.
Matthieu JungIGBMC Microarray and Sequencing Platform, Illkirch, France.ORCID 0000-0002-3272-7322
Serge VicaireIGBMC Microarray and Sequencing Platform, Illkirch, France.ORCID 0000-0001-9339-9513
Clemence VanlerbergheDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.ORCID 0000-0003-3884-2054
Fabienne EscandeEA7364 RADEME (Research Team on Rare Developmental and Metabolic Diseases), Lille 2 University, Lille, France.
Florence PetitDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.ORCID 0000-0002-1368-1023
Sylvie Manouvrier-HanuDepartment of Medical Genetics, Lille University Hospital, CHU Lille, Lille, France.
Lille’s Cardiology Hospital · FRUniversité de Lille · FRCentre Hospitalier Universitaire de Lille · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRHôpital Femme Mère Enfant · FRInstitute Cancer De La Loire Lucien Neuwirth · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBlepharocheilodontic (BCD) syndrome is a rare autosomal dominant condition characterized by eyelid malformations, cleft lip/palate, and ectodermal dysplasia. The molecular basis of BCD syndrome remains unknown.

methodsWe recruited 11 patients from 8 families and performed exome sequencing for 5 families with de novo BCD syndrome cases and targeted Sanger sequencing in the 3 remaining families.

resultsWe identified five CDH1 heterozygous missense mutations and three CTNND1 heterozygous truncating mutations leading to loss-of-function or haploinsufficiency. Establishment of detailed genotype-phenotype correlations was not possible because of the size of the cohort; however, the phenotype seems to appear more severe in case of CDH1 mutations. Functional analysis of CDH1 mutations confirmed their deleterious impact and suggested accelerated E-cadherin degradation.

conclusionMutations in CDH1 encoding the E-cadherin were previously reported in hereditary diffuse gastric cancer as well as in nonsyndromic cleft lip/palate. Mutations in CTNND1 have never been reported before. The encoded protein, p120ctn, prevents E-cadherin endocytosis and stabilizes its localization at the cell surface. Conditional deletion of Cdh1 and Ctnnd1 in various animal models induces features reminiscent of BCD syndrome and underlines critical role of the E-cadherin-p120ctn interaction in eyelid, craniofacial, and tooth development. Our data assert BCD syndrome as a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1 and widen the phenotypic spectrum of E-cadherin anomalies.Genet Med advance online publication 09 March 2017.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseMutationAntigens, CDCadherinsCateninsCell LineCleft LipCleft PalateComputational BiologyDelta CateninDNA Mutational AnalysisEctropionExonsFaciesFemaleAntigens, CDCadherinsCateninsCDH1 protein, humanCTNND1 protein, humanDelta Catenin

Identifiers

PMID28301459
OpenAlexW2596163236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.